Search

everythinglearnresearchcommunity

for

Search:↓

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Low-dose isotretinoin combined with pulsed azithromycin cleared acne in most patients, with mild side effects.

Early advanced therapies are crucial for better survival in aggressive insulinoma cases.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Low-dose oral minoxidil improved hair growth when topical treatments failed.

TPA is about 50 times more effective at promoting tumors than MZ.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Mogamulizumab can cause hair loss, often linked to a better treatment response.

Upadacitinib effectively treats psoriasis and lichen planus together.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

A new method efficiently creates biaryl N-oxides with potential for cancer treatment and drug development.

Increased ODC expression makes normally tumor-resistant mice more prone to tumor development.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Nanoparticle systems make cancer treatment less toxic.

Tofacitinib may help regrow hair in alopecia areata patients.